Our professionals

Dr. Nicolás Pérez

Specialist in Otolaryngology.
Co-Director of the Department of Otolaryngology.
Primary focus on balance disorders.

Works at: Madrid headquarters

Be part of: Clínica Universidad de Navarra

INDEX H 30

Professional career

MD (1985) and PhD in Medicine and Surgery (1997), University of Navarra. Specialist in Otolaryngology, Clínica Universidad de Navarra.

He completed visiting stays at the Massachusetts Eye and Ear Infirmary, Harvard Medical School; Klinikzentrum Basel, University of Basel, Division of Audiology and Neurotology, University Hospital Basel; and the Ocular Motor Laboratory, Johns Hopkins Center for Hearing and Balance.

Currently, Co-Director of the Department of Otolaryngology at the Madrid campus.

Deputy Medical Director of Clínica Universidad de Navarra at the Madrid campus from 2020 to 2025.

RESEARCH AREAS

He has participated in 14 research projects in his specialty, including:

Otophathology: methods and experimental models
Study of the efficacy of betahistine in Ménière’s disease through analysis of variations in summating potential and otoacoustic emissions
Efficacy of trimetazidine 80 mg prolonged release in recurrent vestibular vertigo: a 2-month multicenter, placebo-controlled study.
Central auditory brainstem implants.
Three-dimensional analysis of the caloric and rotational vestibulo-ocular reflex in a normal population and the effects of aging.
Detection of cochlear hydrops in the asymptomatic ear of patients with unilateral Ménière’s disease.
Double-blind, placebo-controlled study of the efficacy and acceptability of V0251 at doses of 1 g, 2 g, and 4 g for vestibular neuritis.
Placebo-controlled, double-blind, randomized clinical evaluation of the efficacy, safety, and tolerability of neramexane in patients with subjective tinnitus.
Open-label, long-term treatment study to evaluate the safety, tolerability, and long-term efficacy of neramexane in patients with subjective tinnitus.
Efficacy and tolerability of V0251 oral suspension in vestibular neuritis.
Deciphering the dissociation of outcomes in vestibular tests in patients with unilateral Ménière’s disease) with file number (PI19/00414) funded by ISCIII: “Health Research Projects (AES 2019). Health projects modality”.

AREAS OF INTEREST

Distortion product otoacoustic emissions in the diagnosis of hearing pathology.
Ménière’s disease
Early detection of neonatal hearing loss: universal screening program using transient evoked otoacoustic emissions.
Development of a clinical protocol for oto-neurologic examination.
Diagnostic testing. Development of an instrumental assessment protocol for patients with dizziness and vertigo using electronystagmography, videonystagmography (2D/3D), sinusoidal and high-frequency rotational stimulation, and dynamic posturography.
Ménière’s disease: diagnostic (glycerol test) and therapeutic criteria (intratympanic gentamicin)
Positional vertigo
Central vestibular syndromes. Differential diagnosis.
New vestibular examination techniques.
Otitis media
Labyrinthitis
Endolymphatic hydrops
Central auditory implant (auditory brainstem implant)
Development of an experimental implant model and assessment of modifications (histologic and functional) in the central auditory pathway.

Activity

In teaching

Positive evaluation as “Assistant Professor (PhD)” by ANECA on January 21, 2004.
Positive evaluation as “Associate Professor (Tenured)” by ANECA on October 30, 2008.
Associate Professor (Tenured) of the Department (Area of Knowledge “Otolaryngology”), University of Navarra, April 7, 2009.
Awarded 4 six-year research terms (sexenios) by the National Commission for the Evaluation of Research Activity (CNEAI) in 2018.
Advanced Research Accreditation in Medical and Health Sciences by the Agència per a la Qualitat del Sistema Universitari de Catalunya.

In research

Has served as a speaker at more than one hundred national and international congresses.
Has written 55 book chapters. Author of 6 full books and editor of 24 books.